Search

Barry Choobin

Examiner (ID: 2847)

Most Active Art Unit
2625
Art Unit(s)
2623, 2721, 2621, 2624, 2625
Total Applications
321
Issued Applications
267
Pending Applications
27
Abandoned Applications
27

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10685788 [patent_doc_number] => 20160031933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'AMINO ACIDS PRODUCED ACCORDING TO A PROCESS OF MECHANOCATALYTIC HYDROLYSIS OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/776500 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11012 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776500 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/776500
AMINO ACIDS PRODUCED ACCORDING TO A PROCESS OF MECHANOCATALYTIC HYDROLYSIS OF PROTEINS Mar 13, 2014 Abandoned
Array ( [id] => 10684486 [patent_doc_number] => 20160030631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis' [patent_app_type] => utility [patent_app_number] => 14/774500 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10626 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774500 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/774500
Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis Mar 12, 2014 Abandoned
Array ( [id] => 10669710 [patent_doc_number] => 20160015855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'SURGICAL METHODS EMPLOYING PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/773262 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 34079 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773262 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/773262
SURGICAL METHODS EMPLOYING PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS Mar 5, 2014 Abandoned
Array ( [id] => 9699400 [patent_doc_number] => 20140249084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS' [patent_app_type] => utility [patent_app_number] => 14/197607 [patent_app_country] => US [patent_app_date] => 2014-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18494 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197607 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/197607
PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS Mar 4, 2014 Abandoned
Array ( [id] => 11894078 [patent_doc_number] => 09763998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Serpins: methods of therapeutic β-cell regeneration and function' [patent_app_type] => utility [patent_app_number] => 14/186054 [patent_app_country] => US [patent_app_date] => 2014-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 17 [patent_no_of_words] => 19846 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186054 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/186054
Serpins: methods of therapeutic β-cell regeneration and function Feb 20, 2014 Issued
Array ( [id] => 10483293 [patent_doc_number] => 20150368312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'INSULIN SECRETING POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/767228 [patent_app_country] => US [patent_app_date] => 2014-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10797 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767228 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/767228
Insulin secreting polypeptides Feb 12, 2014 Issued
Array ( [id] => 10428993 [patent_doc_number] => 20150314003 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2015-11-05 [patent_title] => 'INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER' [patent_app_type] => utility [patent_app_number] => 14/179042 [patent_app_country] => US [patent_app_date] => 2014-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 62640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179042 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/179042
INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANONIC POLYMER Feb 11, 2014 Abandoned
Array ( [id] => 10428993 [patent_doc_number] => 20150314003 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2015-11-05 [patent_title] => 'INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER' [patent_app_type] => utility [patent_app_number] => 14/179042 [patent_app_country] => US [patent_app_date] => 2014-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 62640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179042 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/179042
INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER Feb 11, 2014 Abandoned
Array ( [id] => 9477793 [patent_doc_number] => 20140135256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'TREATMENT OF EXTRACELLULAR MATRIX TO REDUCE INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 14/159129 [patent_app_country] => US [patent_app_date] => 2014-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21759 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14159129 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/159129
Treatment of extracellular matrix to reduce inflammation Jan 19, 2014 Issued
Array ( [id] => 10431532 [patent_doc_number] => 20150316544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'RELEASABLE MAGNETIC CELL CAPTURE SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/653410 [patent_app_country] => US [patent_app_date] => 2014-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5612 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653410 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/653410
RELEASABLE MAGNETIC CELL CAPTURE SYSTEM Jan 13, 2014 Abandoned
Array ( [id] => 10444598 [patent_doc_number] => 20150329612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'PROCESS FOR PURIFYING INSULIN AND ANALOGUES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/652494 [patent_app_country] => US [patent_app_date] => 2013-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7870 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652494 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/652494
Process for purifying insulin and analogues thereof Dec 11, 2013 Issued
Array ( [id] => 10399437 [patent_doc_number] => 20150284446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'SYNTHETIC LINEAR APELIN MIMETICS FOR THE TREATMENT OF HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 14/440198 [patent_app_country] => US [patent_app_date] => 2013-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32476 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440198 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/440198
Synthetic linear apelin mimetics for the treatment of heart failure Nov 18, 2013 Issued
Array ( [id] => 9491739 [patent_doc_number] => 20140142145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'COMBINATIONS COMPRISING A DIPEPTIDYLPEPTIDASE - IV INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/075556 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12767 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075556 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/075556
COMBINATIONS COMPRISING A DIPEPTIDYLPEPTIDASE - IV INHIBITOR Nov 7, 2013 Abandoned
Array ( [id] => 9408192 [patent_doc_number] => 20140099444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'COMPOSITES CONTAINING POLYPEPTIDES ATTACHED TO POLYSACCHARIDES AND MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/073833 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073833 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/073833
COMPOSITES CONTAINING POLYPEPTIDES ATTACHED TO POLYSACCHARIDES AND MOLECULES Nov 5, 2013 Abandoned
Array ( [id] => 10388061 [patent_doc_number] => 20150273069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/436126 [patent_app_country] => US [patent_app_date] => 2013-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16746 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436126 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/436126
FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY Oct 15, 2013 Abandoned
Array ( [id] => 9330142 [patent_doc_number] => 20140056924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA' [patent_app_type] => utility [patent_app_number] => 14/045332 [patent_app_country] => US [patent_app_date] => 2013-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4954 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045332 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/045332
GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA Oct 2, 2013 Abandoned
Array ( [id] => 10325740 [patent_doc_number] => 20150210744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'GLUCAGON ANALOGUES' [patent_app_type] => utility [patent_app_number] => 14/417074 [patent_app_country] => US [patent_app_date] => 2013-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14451 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417074 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/417074
Glucagon analogues Jul 22, 2013 Issued
Array ( [id] => 10805355 [patent_doc_number] => 20160151512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'Cell-Penetrating Peptide, Conjugate Comprising Same and Composition Comprising Same' [patent_app_type] => utility [patent_app_number] => 14/413732 [patent_app_country] => US [patent_app_date] => 2013-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 19249 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413732 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/413732
Cell-penetrating peptide, conjugate comprising same and composition comprising same Jul 10, 2013 Issued
Array ( [id] => 10226827 [patent_doc_number] => 20150111820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'NOVEL USE OF INSULIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/408066 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6860 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408066 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/408066
NOVEL USE OF INSULIN DERIVATIVES Jul 7, 2013 Abandoned
Array ( [id] => 11342380 [patent_doc_number] => 09526766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Potentiation of antibiotic treatment with a protein-lipid complex' [patent_app_type] => utility [patent_app_number] => 14/412104 [patent_app_country] => US [patent_app_date] => 2013-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 25205 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412104 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/412104
Potentiation of antibiotic treatment with a protein-lipid complex Jul 4, 2013 Issued
Menu